Registration

Inauguration

Chairman's Welcome and Inaugural Talk

Renaissance in Pharmacognosy: The Need is Great and the Time is Now
Rathnam Chaguturu, CEO, Innovation Czar-iDDPartners, United States of America

Memento Presentation

Coffee and Networking in Exhibition Area

A Novel Approach to Rescue the Neurodegenerative Diseases with the Modified Peptides Derived from Neuron Specific Kinase (Cdk5)
Harish Pant, Senior Investigator, National Institute of Health, United States of America

Chemical Biology Approaches for Target Identification in "Activity Based Proteomic Profiling" Session
Maria Costi, Professor, University of Modena and Reggio Emilia, Italy

Technology Spotlight:
Using Protein Design Tools to Guide Pharmacophore Generation and Screening
Anand Krishnamurthy, Senior Scientist, Accelrys-BIOVIA

Rethinking Drug Discovery: Going-in for Signaling Pathways and Novel Chemical Space to Hunt for Next Generation Functional Small Molecules
Prabhat Arya, Professor and Head, Dr Reddy's Institute of Life Sciences, India

Lunch and Networking in Exhibition Area

Drugs through Mimicking the Actions of Glycosaminoglycans - Anticoagulants, AntiEmphysema/COPD and Anti-Cancer Stem Cells
Umesh Desai, Professor, Virginia Commonwealth University, United States of America

Technology Spotlight:
Maximising Value and Success with Automation
Lesley Schultz, Product Manager, Agilent Technologies

Special Lecture: Protein Ubiquitination Enzymes as Novel Cancer Therapeutic Targets
Amit Banerjee, Professor, Wayne State University , United States of America

Advances in Developing Tankyrase Selective Inhibitors
Stefan Krauss, Director, University Of Oslo, Norway

Molecular Methods that Enable Targeted Therapeutics and Precision Medicine
Manohar Furtado, Founder and President, Biology For Global Good Consulting Llc, United States of America

End of First Day of Conference

FREE WORKSHOP: RNA Silencing for Drug Discovery- Challenges and Strategies

Plenary Presentation: Bioprocessing of Human Pluripotent Stem Cells using CompacT SelecT Cell Culture Automation
Yacine Laabi, Research Group Leader, Institute for Stem Cell Therapy and Exploration of Monogenic Diseases, France

Stem Cell Based Chip Platforms In Drug Discovery
Subadra Dravida, Founder CEO, Tran-Scell Biologics Pvt. Ltd., India

Technology Spotlight:
Fluent Laboratory Automation Solution for Cell based Assays
Roland Durner, Global Head of LSB Distributors, Tecan Trading AG

Coffee Break and Networking in Exhibition Area

Annotating Biological Activities of Drugs, Natural Products and Environmental Toxicants by FACTORIAL Pathway Profiling Assays
Sergei Makarov, Chief Executive Officer, Attagene Inc, United States of America

Cell Based Assays in Clinical Diagnostics: Applications to Neutralizing Antibody Assays, Pharmacogenomics and Personalized Medicine
John Watson, Director of Marketing, Promega Corporation, United States of America

Optimisation of New Trypanosoma brucei Inhibitors
Raphael Rahmani, Research Fellow, Monash University, Australia

Repositioning of Drugs- Structure-Based Approach Towards Finding New Leads as Antileishmanial Agents
Sanjay Batra, Principal Scientist, CSIR Central Drug Research Institute, India

Special Lecture: Natural Products Repurposing for Cancer Therapy
Petr Bartunek, Group Leader, Institute of Molecular Genetics, Czech Republic

Lunch and Networking in Exhibition Area

POSTER EVALUATION

Accelerated and Reliable Lead Discovery: Structure Guided Drug Discovery Ideal for Collaborative Projects
Kal Ramnarayan, President and Chief Scientific Officer, Sapient Discovery, United States of America

Opportunities for Strategic Research Partnerships in Drug Discovery
Ajith Kamath, Head, Pfizer Inc, India

Crowdsourcing Systems Level Platform for Open Source Drug Discovery
Anshu Bhardwaj, Scientist, CSIR- Open Drug Discovery Unit, India

Open Source Drug Discovery for Tuberculosis: Lessons to learn
Anamik Shah, Vice Chancellor, Gujarat Vidyapith, India

Open Discussion on Open Source Drug Discovery

Coffee Break and Networking in Exhibition Area

Panel Discussion: Drug Discovery- Contract Research Landscape in India 2020

End of the Conference